Cegedim SA

  • Market Cap: N/A
  • Industry: Software Products
  • ISIN: FR0000053506
EUR
13.25
-0.05 (-0.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Cegedim SA stock-summary
stock-summary
Cegedim SA
Software Products
Cegedim SA is a France-based company that produces and distributes data and services linked to medical information and customer relationship management (CRM) activities for the Sales and Marketing Departments in the Healthcare and Life Sciences sectors. Cegedim is also a manufacturer of medical and para-medical management software, and designs management applications dedicated to the health insurance sector. The Company’s expertise falls into three sectors: Life Sciences which comprises solutions specifically designed for pharmaceutical companies; Healthcare professionals designed for doctors, pharmacists and paramedics, and Healthcare Insurance, which is designed for health insurance providers and for companies of any sectors. The Company operates through Webstar Health and a number of subsidiaries. Cegedim SA is present in approximately 80 countries around the world.
Company Coordinates stock-summary
Company Details
137 rue d'Aguesseau , BOULOGNE-BILLANCOURT None : 92100
stock-summary
Tel: 33 1 4909220033 1 49093336
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Jean-Claude Labrune
Chairman of the Board, Chief Executive Officer
Mr. Laurent Labrune
Deputy Chief Executive Officer, Director
Mr. Pierre Marucchi
Deputy Chief Executive Officer, Director - Representative of FCB
Ms. Catherine Abiven
Non-Executive Director
Ms. Sandrine Debroise
Non-Executive Director
Mr. Nicolas Giraud
Non-Executive Director - Representative of GERS
Ms. Aude Labrune-Marysse
Non-Executive Director
Mr. Jean-Pierre Cassan
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
123 Million
(Quarterly Results - Dec 2016)
Net Profit:
-10 Million
stock-summary
Industry

Software Products

stock-summary
Market cap

EUR 187 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.74

stock-summary
Return on Equity

-4.61%

stock-summary
Price to Book

0.71